Zolazepam hydrochloride
CAS: 33754-49-3
Ref. 3D-FZ61533
| 5mg | 352.00 € | ||
| 10mg | 579.00 € | ||
| 25mg | 1,158.00 € | ||
| 50mg | 2,104.00 € |
Product Information
- 4-(2-fluorophenyl)-1,3,8-trimethyl-6,8-dihydropyrazolo[3,4-e][1,4]diazepin-7(1H)-one hydrochloride (1:1)
- 4-(o-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo(3,4-e)(1,4)diazepin-7(1H)-one monohydrochloride
- Ci 716
- Pyrazolo(3,4-e)(1,4)diazepin-7(1H)-one, 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-, monohydrochloride
- Pyrazolo[3,4-e][1,4]diazepin-7(1H)-one, 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethyl-, hydrochloride (1:1)
- Telazol
- Unii-45Sj093Q1N
- Zolazepam HCl
- Zolazepam hydrochloride [USAN]
- 4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo(3,4-e)(1,4)diazepin-7(1H)-one monohydrochloride
- See more synonyms
Zolazepam is a benzodiazepine that has antinociceptive properties and is used as an anesthetic. The effective dose of zolazepam in humans is 5-10 mg intravenously, with a maximum dose of 25 mg. Zolazepam has been found to have no effect on systolic blood pressure or heart rate, but does cause significant reduction in terminal half-life. Zolazepam's antinociceptive effects are mediated through the inhibition of calcium ion channels, which results in decreased neuronal activity in the spinal cord and brainstem. Zolazepam causes sedation and immobilization by suppressing the function of neurons that control skeletal muscles.
Zolazepam also has been shown to inhibit osteoclast formation, which may be beneficial for patients with metabolic bone diseases such as Paget's disease or osteoporosis.
Chemical properties
Technical inquiry about: 3D-FZ61533 Zolazepam hydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
